Detected ·
BMI OrganBank
——
BMI OrganBank, a company developing next-generation organ preservation technology for kidneys, has received an investment from Cowtown Angels alongside Golden Seeds, TCA Venture Group, and Band of Angels. The company holds FDA Breakthrough Device Designation (2025) and has developed a room-temperature organ preservation platform that keeps kidneys metabolically active without donated blood.
- Website
- bmiorganbank.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-17 16:44:55 UTC
- Signal ID
- e5ab99db-df89-4e60-a690-ba4dae26f94b
As the API returns it
{
"id": "e5ab99db-df89-4e60-a690-ba4dae26f94b",
"created_at": "2026-07-17T16:44:55.062115Z",
"company_name": "BMI OrganBank",
"company_website_url": "bmiorganbank.com",
"company_linkedin_url": "https://www.linkedin.com/company/bmiorganbank",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*BMI OrganBank, a company developing next-generation organ preservation technology for kidneys, has received an investment from Cowtown Angels alongside Golden Seeds, TCA Venture Group, and Band of Angels. The company holds FDA Breakthrough Device Designation (2025) and has developed a room-temperature organ preservation platform that keeps kidneys metabolically active without donated blood.*"
}